Vasculitis medical therapy: Difference between revisions

	Vasculitis
Overview
Classification Large-sized vessel vasculitis Takayasu's Arteritis Temporal Arteritis Medium-sized vessel vasculitis Kawasaki's Disease Polyarteritis Nodosa Small-sized vessel vasculitis Churg-Strauss Syndrome Cutaneous leukocytoclastic vasculitis Essential cryoglobulinemic vasculitis Henoch-Schonlein Purpura Microscopic polyangiitis Wegener's Granulomatosis Variable-sized vessel vasculitis Sjogren syndrome Cogan syndrome Single organ vasculitis Primary central nervous system angiitis
Causes
Differential Diagnosis

Latest revision as of 20:48, 31 January 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: M.Umer Tariq [2]

@@ Line 7: / Line 7: @@
 ==Medical Therapy==
-Treatment is targeted to the underlying cause. However, most vasculitis in general are treated with [[steroid]]s (e.g. [[methylprednisolone]]) because the underlying cause of the vasculitis is due to hyperactive immunological damage. Immunosuppressants such as [[cyclophosphamide]] and [[azathioprine]] may also be given.
-A [[systematic review]] of [[antineutrophil cytoplasmic antibody]] (ANCA) positive vasculitis indentified best treatments depending on whether the goal is to induce remission or maintenance and depending on severity of the vasculitis.<ref name="pmid17684188">{{cite journal |author=Bosch X, Guilabert A, Espinosa G, Mirapeix E |title=Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review |journal=JAMA |volume=298 |issue=6 |pages=655-69 |year=2007 |pmid=17684188 |doi=10.1001/jama.298.6.655}}</ref>
 ==References==
 {{Reflist|2}}
+[[Category:Rheumatology]]
 {{WH}}
 {{WS}}